Drug interactions and drug-food interactions in patients receiving diabetes mellitus treatment

Author:

Duniya Sheneni Victor,Eleojo Shaibu Isaac

Abstract

Drug interaction is the change of a drug's effects by the preceding and/or concurrent administration of a different substance (precipitant drug). Drug interactions may either intensify or weaken the effects that one or both medications are supposed to have. Any drug's therapeutic, preventative, or diagnostic capabilities may change as a result. A major contributing factor to the prevalence and occurrence of adverse medication responses and adverse drug events might be drug interactions. Patients receiving drug combinations or polypharmacy or suffering from co-morbid diseases like diabetes, hypertension, peptic ulcer, fungal infections, and neurodegenerative disorders have a much higher rate of occurrence and incidence of drug interactions. As these patients receive prolonged and multiple treatments, the risk of drug interactions rises. Conclusion: Drug interactions are more likely to occur in diabetes patients who are also getting a mix of medications for diabetic complications. As a result, the frequency of drug interactions is fast increasing. Because of its increasing incidence and the corresponding rise in morbidity and mortality, diabetes mellitus has been regarded as a major public health concern globally. The major goal of this review study is to highlight the different medication interactions that may occur between drugs and foods, as well as to record any unfavorable side effects of other treatments used in conjunction with antidiabetic drugs in diabetic patients.

Publisher

MedCrave Group, LLC

Reference48 articles.

1. 1. Radhika B, Subash V, Ramaiyan D. A pharmacokinetic interaction of pioglitazone and its clinical applications a short review. Int J Pharm Sci Letters. 2012;2(1):1-9.

2. Dapagliflozin in patients with type 2 diabetes mellitus;Theodosios;Ther Adv Endocrinol Metab,2015

3. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation;Matheny;Pharmacotherapy,2001

4. 4. Janadri S, Ramachandra SS, Kharya MD. Influence of itraconazole on antidiabetic effect of thiazolidinedione in diabetic rats. International Journal of Pharmacy and Pharmaceutical Sciences. 2009;1(1):119-24.

5. 5. Sen. A study on drug-drug interaction between anti-hypertensive drug (propranolol) and anti-diabetic drug (glipizide). Annals of Biological Research. 2010;1(3):35-40.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3